OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.620
0.00 (0.00%)
At close: Mar 27, 2026

HKG:6929 Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
180.45164.1153.87136.82116.46
Revenue Growth (YoY)
9.97%6.65%12.46%17.48%31.64%
Cost of Revenue
58.0249.6347.3744.3735.29
Gross Profit
122.43114.47106.592.4681.17
Selling, General & Admin
67.3862.754.8455.1350.06
Research & Development
15.7317.0514.3814.1112.15
Other Operating Expenses
-0.69-0.44-2.14-0.92-1.4
Operating Expenses
83.0979.6567.1468.5760.7
Operating Income
39.3434.8239.3623.8920.48
Interest Expense
-0.17-0.22-0.13-1.46-5.61
Interest & Investment Income
8.8611.9210.672.390.01
Earnings From Equity Investments
-1.32-1.51-0.84-0.2-0.21
Currency Exchange Gain (Loss)
0.78-0.71-0.36-0.97-0.9
Other Non Operating Income (Expenses)
-0.03-0-0.01-0.01-0
EBT Excluding Unusual Items
47.4744.348.6923.6513.77
Impairment of Goodwill
--1.57---
Gain (Loss) on Sale of Investments
-0.24-0.280.98-1.49-0.05
Gain (Loss) on Sale of Assets
-0.1-0.01-0.05-0.03-0.08
Asset Writedown
----0.34-
Other Unusual Items
-0.05-0.030.010-14.96
Pretax Income
47.0942.4149.6321.79-1.32
Income Tax Expense
5.052.564.563.33.13
Earnings From Continuing Operations
42.0339.8545.0718.49-4.44
Minority Interest in Earnings
-0.13-0.13---
Net Income
41.939.7245.0718.49-4.44
Net Income to Common
41.939.7245.0718.49-4.44
Net Income Growth
5.49%-11.88%143.76%--
Shares Outstanding (Basic)
824826828583577
Shares Outstanding (Diluted)
826826833776577
Shares Change (YoY)
-0.09%-0.80%7.29%34.58%-
EPS (Basic)
0.050.050.050.03-0.01
EPS (Diluted)
0.050.050.050.03-0.01
EPS Growth
5.62%-11.09%111.85%--
Free Cash Flow
-3.3217.4320.5319.25
Free Cash Flow Per Share
-0.000.020.030.03
Dividend Per Share
0.0150.0130.013--
Dividend Growth
20.31%----
Gross Margin
67.85%69.76%69.22%67.57%69.70%
Operating Margin
21.80%21.22%25.58%17.46%17.58%
Profit Margin
23.22%24.20%29.29%13.51%-3.82%
Free Cash Flow Margin
-2.02%11.33%15.01%16.53%
EBITDA
42.1337.6141.325.8422.86
EBITDA Margin
23.35%22.92%26.84%18.89%19.63%
D&A For EBITDA
2.792.791.941.952.39
EBIT
39.3434.8239.3623.8920.48
EBIT Margin
21.80%21.22%25.58%17.46%17.58%
Effective Tax Rate
10.73%6.04%9.18%15.14%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.